Assetmark, Inc Bio Rad Laboratories, Inc. Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 305 shares of BIO stock, worth $100,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares

305

Previous 165 84.85%

Holding current value

$100,878

Previous $45,000 126.67%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$263.97 - $344.64 $36,955 - $48,249	140 Added 84.85%	305 $102,000
Q2 2024 Aug 13, 2024	SELL	$268.26 - $339.48 $4.51 Million - $5.7 Million	-16,794 Reduced 99.03%	165 $45,000
Q1 2024 May 06, 2024	BUY	$304.11 - $351.99 $4,865 - $5,631	16 Added 0.09%	16,959 $5.87 Million
Q4 2023 Feb 09, 2024	SELL	$269.37 - $365.04 $501,297 - $679,339	-1,861 Reduced 9.9%	16,943 $5.47 Million
Q3 2023 Oct 27, 2023	BUY	$350.25 - $422.63 $436,411 - $526,596	1,246 Added 7.1%	18,804 $6.74 Million
Q2 2023 Aug 11, 2023	SELL	$359.49 - $486.4 $336,842 - $455,756	-937 Reduced 5.07%	17,558 $6.66 Million
Q1 2023 May 05, 2023	BUY	$418.69 - $503.0 $577,792 - $694,140	1,380 Added 8.06%	18,495 $8.86 Million
Q4 2022 Feb 10, 2023	SELL	$351.71 - $456.01 $770,948 - $999,573	-2,192 Reduced 11.35%	17,115 $7.2 Million
Q3 2022 Nov 01, 2022	SELL	$412.59 - $563.26 $46.7 Million - $63.8 Million	-113,290 Reduced 85.44%	19,307 $8.05 Million
Q2 2022 Aug 03, 2022	SELL	$463.67 - $597.16 $5.38 Million - $6.93 Million	-11,599 Reduced 8.04%	132,597 $65.6 Million
Q1 2022 May 13, 2022	SELL	$524.57 - $735.42 $826,722 - $1.16 Million	-1,576 Reduced 1.08%	144,196 $81.2 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $4.92 Million - $5.51 Million	6,935 Added 5.0%	145,772 $110 Million
Q3 2021 Nov 12, 2021	SELL	$657.71 - $825.77 $4.77 Million - $5.99 Million	-7,253 Reduced 4.96%	138,837 $104 Million
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $3.87 Million - $4.36 Million	6,713 Added 4.82%	146,090 $94.1 Million
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $4.84 Million - $5.86 Million	8,842 Added 6.77%	139,377 $79.6 Million
Q4 2020 Feb 10, 2021	BUY	$510.68 - $643.45 $236,444 - $297,917	463 Added 0.36%	130,535 $76.1 Million
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $22.8 Million - $26.8 Million	50,096 Added 62.64%	130,072 $67 Million
Q2 2020 Aug 11, 2020	BUY	$334.87 - $493.06 $21.3 Million - $31.3 Million	63,478 Added 384.76%	79,976 $34.6 Million
Q1 2020 May 12, 2020	BUY	$320.01 - $409.07 $5.28 Million - $6.75 Million	16,498 New	16,498 $5.78 Million
Q1 2019 May 14, 2019	SELL	$224.3 - $317.41 $1,121 - $1,587	-5 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$220.1 - $309.0 $4,181 - $5,871	-19 Reduced 79.17%	5 $1,000
Q3 2018 Nov 13, 2018	BUY	$289.28 - $326.15 $6,942 - $7,827	24 New	24 $8,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account